Lahouaria Hadri

Dr. Lahouaria Hadri

Icahn School of Medicine at Mount Sinai, New York, USA
orcid

Biography

Lahouaria Hadri graduated from the University of Paris XI, Faculty of Pharmacy, Châtenay-Malabry, in 2005. In 2006, she relocated to the United States and undertook a postdoc position at Massachusetts General Hospital, Harvard Medical School, in Boston, and in 2007, she moved to Icahn School of Medicine at Mount Sinai in New York City with the team. The Hadri Lab focuses on cardiovascular diseases, pulmonary arterial hypertension (PAH), and idiopathic pulmonary fibrosis (IPF). Its current research objectives are to provide an in-depth analysis of calcium-handling proteins’ roles and their cellular signaling networks in cardiovascular and lung diseases and to define a platform for the design of innovative therapeutic strategies using gene- and drug-targeted therapies. The lab also has a particular interest in exploring the role of epigenetic modifications and SIN3a/histone deacetylase complex in various cardiopulmonary diseases.

Affiliations

Icahn School of Medicine at Mount Sinai

New York, USA

Honors and Awards

No honors or awards have been shared yet.

Experience

No experience has been shared yet.